Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor

Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor

A 43-year-old male patient with C5 giant cell tumor (GCT) underwent tumor resection and anterior bone fusion of C4–C6. The tumor recurred locally 9 months after surgery with the patient complaining of neck and shoulder pain similar to his preoperative symptoms. Denosumab was administered and his pai...

Full description

Bibliographic Details
Main Authors: Kajiwara, Daisuke, Kamoda, Hiroto, Yonemoto, Tsukasa, Iwata, Shintaro, Ishii, Takeshi, Tsukanishi, Toshinori, Ohtori, Seiji, Yamazaki, Masashi, Okawa, Akihiko
Format: Online
Language:English
Published: Korean Society of Spine Surgery 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917776/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917776/

Similar Items